Focal Choroidal Excavation Complicated by Choroidal Neovascularization
To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV). Retrospective, observational case series. Twelve patients (15 eyes) with FCE and CNV. The medical records of the patients were reviewed. Clinical findings including age, sex, refr...
Saved in:
Published in | Ophthalmology (Rochester, Minn.) Vol. 121; no. 1; pp. 246 - 250 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.01.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV).
Retrospective, observational case series.
Twelve patients (15 eyes) with FCE and CNV.
The medical records of the patients were reviewed. Clinical findings including age, sex, refraction, color photography, fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), and spectral-domain optical coherence tomography (OCT) were analyzed.
Fundus fluorescein angiography, ICGA, and OCT findings.
The 12 patients included 6 women and 6 men. The mean age was 46.8±13.4 years (range, 26-64 years). One half of the patients were emmetropic, and the others were myopic (−0.5 to −3.0 diopters). All subjects were Chinese. Before CNV development, normal appearance or nonspecific pigment disturbance could be seen around the choroidal excavation. Corresponding to the excavation, window defects were observed by FFA, whereas hypofluorescence was found on ICGA images. Choroidal neovascularization in all eyes was classic as revealed by FFA. The OCT images showed that all eyes had a single choroidal excavation. In 7 of the 15 eyes, the choroidal excavation was located subfoveally, and in the other 8 eyes, it was eccentric. All CNV lesions grew from the bottom or slope of the excavation. Three patients had bilateral involvement. Choroidal neovascularization occurred in both conforming and nonconforming type FCEs, regardless of whether the excavation was shallow or deep, subfoveal or eccentric. All CNV lesions responded well to intravitreal injection of anti–vascular endothelial growth factor (VEGF) agents. After a single injection, CNV regressed in 13 of 15 eyes. Two eyes received an additional injection. Nonconforming FCE changed to the conforming type after successful treatment of CNV.
Focal choroidal excavation is not always stable. Choroidal neovascularization commonly can be seen in patients with FCE and responds well to intravitreal anti-VEGF agents. |
---|---|
AbstractList | To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV).PURPOSETo evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV).Retrospective, observational case series.DESIGNRetrospective, observational case series.Twelve patients (15 eyes) with FCE and CNV.PARTICIPANTSTwelve patients (15 eyes) with FCE and CNV.The medical records of the patients were reviewed. Clinical findings including age, sex, refraction, color photography, fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), and spectral-domain optical coherence tomography (OCT) were analyzed.METHODSThe medical records of the patients were reviewed. Clinical findings including age, sex, refraction, color photography, fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), and spectral-domain optical coherence tomography (OCT) were analyzed.Fundus fluorescein angiography, ICGA, and OCT findings.MAIN OUTCOME MEASURESFundus fluorescein angiography, ICGA, and OCT findings.The 12 patients included 6 women and 6 men. The mean age was 46.8±13.4 years (range, 26-64 years). One half of the patients were emmetropic, and the others were myopic (-0.5 to -3.0 diopters). All subjects were Chinese. Before CNV development, normal appearance or nonspecific pigment disturbance could be seen around the choroidal excavation. Corresponding to the excavation, window defects were observed by FFA, whereas hypofluorescence was found on ICGA images. Choroidal neovascularization in all eyes was classic as revealed by FFA. The OCT images showed that all eyes had a single choroidal excavation. In 7 of the 15 eyes, the choroidal excavation was located subfoveally, and in the other 8 eyes, it was eccentric. All CNV lesions grew from the bottom or slope of the excavation. Three patients had bilateral involvement. Choroidal neovascularization occurred in both conforming and nonconforming type FCEs, regardless of whether the excavation was shallow or deep, subfoveal or eccentric. All CNV lesions responded well to intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents. After a single injection, CNV regressed in 13 of 15 eyes. Two eyes received an additional injection. Nonconforming FCE changed to the conforming type after successful treatment of CNV.RESULTSThe 12 patients included 6 women and 6 men. The mean age was 46.8±13.4 years (range, 26-64 years). One half of the patients were emmetropic, and the others were myopic (-0.5 to -3.0 diopters). All subjects were Chinese. Before CNV development, normal appearance or nonspecific pigment disturbance could be seen around the choroidal excavation. Corresponding to the excavation, window defects were observed by FFA, whereas hypofluorescence was found on ICGA images. Choroidal neovascularization in all eyes was classic as revealed by FFA. The OCT images showed that all eyes had a single choroidal excavation. In 7 of the 15 eyes, the choroidal excavation was located subfoveally, and in the other 8 eyes, it was eccentric. All CNV lesions grew from the bottom or slope of the excavation. Three patients had bilateral involvement. Choroidal neovascularization occurred in both conforming and nonconforming type FCEs, regardless of whether the excavation was shallow or deep, subfoveal or eccentric. All CNV lesions responded well to intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents. After a single injection, CNV regressed in 13 of 15 eyes. Two eyes received an additional injection. Nonconforming FCE changed to the conforming type after successful treatment of CNV.Focal choroidal excavation is not always stable. Choroidal neovascularization commonly can be seen in patients with FCE and responds well to intravitreal anti-VEGF agents.CONCLUSIONSFocal choroidal excavation is not always stable. Choroidal neovascularization commonly can be seen in patients with FCE and responds well to intravitreal anti-VEGF agents. To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV). Retrospective, observational case series. Twelve patients (15 eyes) with FCE and CNV. The medical records of the patients were reviewed. Clinical findings including age, sex, refraction, color photography, fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), and spectral-domain optical coherence tomography (OCT) were analyzed. Fundus fluorescein angiography, ICGA, and OCT findings. The 12 patients included 6 women and 6 men. The mean age was 46.8±13.4 years (range, 26-64 years). One half of the patients were emmetropic, and the others were myopic (−0.5 to −3.0 diopters). All subjects were Chinese. Before CNV development, normal appearance or nonspecific pigment disturbance could be seen around the choroidal excavation. Corresponding to the excavation, window defects were observed by FFA, whereas hypofluorescence was found on ICGA images. Choroidal neovascularization in all eyes was classic as revealed by FFA. The OCT images showed that all eyes had a single choroidal excavation. In 7 of the 15 eyes, the choroidal excavation was located subfoveally, and in the other 8 eyes, it was eccentric. All CNV lesions grew from the bottom or slope of the excavation. Three patients had bilateral involvement. Choroidal neovascularization occurred in both conforming and nonconforming type FCEs, regardless of whether the excavation was shallow or deep, subfoveal or eccentric. All CNV lesions responded well to intravitreal injection of anti–vascular endothelial growth factor (VEGF) agents. After a single injection, CNV regressed in 13 of 15 eyes. Two eyes received an additional injection. Nonconforming FCE changed to the conforming type after successful treatment of CNV. Focal choroidal excavation is not always stable. Choroidal neovascularization commonly can be seen in patients with FCE and responds well to intravitreal anti-VEGF agents. Purpose To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV). Design Retrospective, observational case series. Participants Twelve patients (15 eyes) with FCE and CNV. Methods The medical records of the patients were reviewed. Clinical findings including age, sex, refraction, color photography, fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), and spectral-domain optical coherence tomography (OCT) were analyzed. Main Outcome Measures Fundus fluorescein angiography, ICGA, and OCT findings. Results The 12 patients included 6 women and 6 men. The mean age was 46.8±13.4 years (range, 26-64 years). One half of the patients were emmetropic, and the others were myopic (−0.5 to −3.0 diopters). All subjects were Chinese. Before CNV development, normal appearance or nonspecific pigment disturbance could be seen around the choroidal excavation. Corresponding to the excavation, window defects were observed by FFA, whereas hypofluorescence was found on ICGA images. Choroidal neovascularization in all eyes was classic as revealed by FFA. The OCT images showed that all eyes had a single choroidal excavation. In 7 of the 15 eyes, the choroidal excavation was located subfoveally, and in the other 8 eyes, it was eccentric. All CNV lesions grew from the bottom or slope of the excavation. Three patients had bilateral involvement. Choroidal neovascularization occurred in both conforming and nonconforming type FCEs, regardless of whether the excavation was shallow or deep, subfoveal or eccentric. All CNV lesions responded well to intravitreal injection of anti–vascular endothelial growth factor (VEGF) agents. After a single injection, CNV regressed in 13 of 15 eyes. Two eyes received an additional injection. Nonconforming FCE changed to the conforming type after successful treatment of CNV. Conclusions Focal choroidal excavation is not always stable. Choroidal neovascularization commonly can be seen in patients with FCE and responds well to intravitreal anti-VEGF agents. To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV). Retrospective, observational case series. Twelve patients (15 eyes) with FCE and CNV. The medical records of the patients were reviewed. Clinical findings including age, sex, refraction, color photography, fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), and spectral-domain optical coherence tomography (OCT) were analyzed. Fundus fluorescein angiography, ICGA, and OCT findings. The 12 patients included 6 women and 6 men. The mean age was 46.8±13.4 years (range, 26-64 years). One half of the patients were emmetropic, and the others were myopic (-0.5 to -3.0 diopters). All subjects were Chinese. Before CNV development, normal appearance or nonspecific pigment disturbance could be seen around the choroidal excavation. Corresponding to the excavation, window defects were observed by FFA, whereas hypofluorescence was found on ICGA images. Choroidal neovascularization in all eyes was classic as revealed by FFA. The OCT images showed that all eyes had a single choroidal excavation. In 7 of the 15 eyes, the choroidal excavation was located subfoveally, and in the other 8 eyes, it was eccentric. All CNV lesions grew from the bottom or slope of the excavation. Three patients had bilateral involvement. Choroidal neovascularization occurred in both conforming and nonconforming type FCEs, regardless of whether the excavation was shallow or deep, subfoveal or eccentric. All CNV lesions responded well to intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents. After a single injection, CNV regressed in 13 of 15 eyes. Two eyes received an additional injection. Nonconforming FCE changed to the conforming type after successful treatment of CNV. Focal choroidal excavation is not always stable. Choroidal neovascularization commonly can be seen in patients with FCE and responds well to intravitreal anti-VEGF agents. |
Author | Sun, Xiaolei Xu, Haifeng Shi, Depeng Bai, Yao Zeng, Fanxing Chen, Xiuli |
Author_xml | – sequence: 1 givenname: Haifeng surname: Xu fullname: Xu, Haifeng email: chxhf@126.com – sequence: 2 givenname: Fanxing surname: Zeng fullname: Zeng, Fanxing – sequence: 3 givenname: Depeng surname: Shi fullname: Shi, Depeng – sequence: 4 givenname: Xiaolei surname: Sun fullname: Sun, Xiaolei – sequence: 5 givenname: Xiuli surname: Chen fullname: Chen, Xiuli – sequence: 6 givenname: Yao surname: Bai fullname: Bai, Yao |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24095605$$D View this record in MEDLINE/PubMed |
BookMark | eNqVktFrFDEQxoNU7LX6H4jcoy-7TpLdTVZEKEdPC0UftNC3kE1muZy5zZnsHp5_vbleC0WQ4tPMw-_7hvlmzsjJEAYk5DWFkgJt3q3LsF2NK10yoLwEWQKtnpEZrau2qATlJ2SWMVo0FYNTcpbSGgCahlcvyCmroK0bqGdkuQxG-_liFWJwNneXv4ze6dGFYb4Im613Ro9o593-EfMFw04nM3kd3e879iV53muf8NV9PSc3y8vvi8_F9ddPV4uL68LUko2FRlNT2jEretNbi0w00nIqba0b3SFALUQtObeMAkeJVGveyB4sdrIF0_Nz8vbou43h54RpVBuXDHqvBwxTUrRqQUAjWpHRN_fo1G3Qqm10Gx336mH3DLw_AiaGlCL2yrjxbpsxaucVBXUIWq3VMWh1CFqBVDnoLK7-Ej_4PyH7eJRhDmnnMKpkHA4GrYtoRmWD-18D492Qj-R_4B7TOkxxyAdQVCWmQH07vMDhAygHEJzdZoMP_zZ4ev4fTJ_DMg |
CitedBy_id | crossref_primary_10_1186_s12886_024_03415_8 crossref_primary_10_1111_cxo_12309 crossref_primary_10_1111_cxo_12265 crossref_primary_10_1111_cxo_12590 crossref_primary_10_1016_j_oftal_2015_10_004 crossref_primary_10_1016_j_survophthal_2024_09_010 crossref_primary_10_3390_app12094472 crossref_primary_10_1080_09273948_2018_1540708 crossref_primary_10_1097_OPX_0000000000000530 crossref_primary_10_1155_2019_7925737 crossref_primary_10_1186_s12886_019_1081_6 crossref_primary_10_12688_f1000research_141099_1 crossref_primary_10_1155_2018_8406857 crossref_primary_10_1111_aos_14683 crossref_primary_10_1177_1120672120981364 crossref_primary_10_1007_s00417_019_04374_3 crossref_primary_10_1177_24741264241294159 crossref_primary_10_1097_IAE_0000000000002980 crossref_primary_10_3341_jkos_2019_60_6_541 crossref_primary_10_1038_eye_2015_31 crossref_primary_10_1097_OPX_0000000000000443 crossref_primary_10_1155_2016_7073083 crossref_primary_10_1097_IAE_0000000000001805 crossref_primary_10_18502_jovr_v15i3_7461 crossref_primary_10_1097_ICB_0000000000000617 crossref_primary_10_4103_ijo_IJO_931_20 crossref_primary_10_1038_s41433_018_0158_4 crossref_primary_10_1007_s00417_021_05487_4 crossref_primary_10_1159_000444681 crossref_primary_10_4103_ijo_IJO_569_20 crossref_primary_10_2147_OPTH_S264731 crossref_primary_10_1007_s00417_021_05445_0 crossref_primary_10_1136_bjophthalmol_2020_316992 crossref_primary_10_4103_ojo_ojo_73_23 crossref_primary_10_3928_23258160_20150101_24 crossref_primary_10_1016_j_ajoc_2021_101078 crossref_primary_10_1097_OPX_0000000000000956 crossref_primary_10_1136_bjophthalmol_2015_307055 crossref_primary_10_1177_1120672120932092 crossref_primary_10_1016_j_preteyeres_2016_04_002 crossref_primary_10_1016_j_heliyon_2024_e36246 crossref_primary_10_1016_j_oftale_2015_12_012 crossref_primary_10_1177_2474126419888135 crossref_primary_10_1097_ICB_0000000000000649 crossref_primary_10_1038_eye_2017_136 crossref_primary_10_4103_ijo_IJO_919_19 crossref_primary_10_1038_s41598_023_49153_7 crossref_primary_10_1007_s00417_021_05450_3 crossref_primary_10_1111_ceo_13775 crossref_primary_10_1177_11206721231198884 crossref_primary_10_4103_ojo_OJO_61_2018 crossref_primary_10_3389_fopht_2022_984903 crossref_primary_10_3390_bioengineering10030377 crossref_primary_10_1097_IAE_0000000000001345 crossref_primary_10_1038_eye_2017_71 crossref_primary_10_1097_IAE_0000000000003926 crossref_primary_10_1177_24741264241305116 crossref_primary_10_1016_j_jfo_2023_05_013 crossref_primary_10_1097_ICB_0000000000000833 crossref_primary_10_1016_j_ajoc_2020_100772 crossref_primary_10_1097_ICB_0000000000000759 |
Cites_doi | 10.1097/01.iae.0000248819.86737.a5 10.2147/OPTH.S33879 10.1097/OPX.0b013e31828736f3 10.1001/archophthalmol.2011.148 10.1111/j.1755-3768.2010.01895.x 10.1097/IAE.0b013e31827b6452 |
ContentType | Journal Article |
Copyright | 2014 American Academy of Ophthalmology American Academy of Ophthalmology Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2014 American Academy of Ophthalmology – notice: American Academy of Ophthalmology – notice: Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.ophtha.2013.08.014 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1549-4713 |
EndPage | 250 |
ExternalDocumentID | 24095605 10_1016_j_ophtha_2013_08_014 S016164201300732X 1_s2_0_S016164201300732X |
Genre | Journal Article |
GroupedDBID | --- --K .1- .55 .FO .GJ 0R~ 123 1B1 1CY 1P~ 1~5 29N 4.4 457 4G. 53G 5RE 5VS 7-5 71M AAEDT AAEDW AALRI AAQFI AAQQT AAQXK AAXUO ABCQX ABFRF ABJNI ABLJU ABMAC ABOCM ABWVN ACGFO ACGFS ACIUM ACNCT ACRPL ACVFH ADCNI ADMUD ADNMO AEFWE AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AGCQF AGQPQ AIGII AITUG AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ BELOY C5W CS3 DU5 EBS EFJIC EFKBS EJD F5P FDB FEDTE FGOYB GBLVA HVGLF HZ~ IHE J1W K-O KOM L7B M27 M41 MO0 N4W N9A NQ- O9- OF- OPF OQ~ P2P R2- ROL RPZ SDG SEL SES SSZ UHS UNMZH UV1 WH7 X7M XH2 XPP Z5R ZGI ZXP ADPAM RIG AAIAV AGZHU AHPSJ ALXNB ZA5 AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c582t-aec511b2d7fcfdde2768d318d5a6abe005775833d2103e8e1aa368f0deb890cf3 |
ISSN | 0161-6420 1549-4713 |
IngestDate | Mon Jul 21 09:57:27 EDT 2025 Thu Apr 03 07:06:31 EDT 2025 Tue Jul 01 03:37:31 EDT 2025 Thu Apr 24 22:53:12 EDT 2025 Fri Feb 23 02:14:11 EST 2024 Sun Feb 23 10:19:11 EST 2025 Tue Aug 26 16:36:58 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c582t-aec511b2d7fcfdde2768d318d5a6abe005775833d2103e8e1aa368f0deb890cf3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://www.aaojournal.org/article/S016164201300732X/pdf |
PMID | 24095605 |
PQID | 1490706797 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_1490706797 pubmed_primary_24095605 crossref_citationtrail_10_1016_j_ophtha_2013_08_014 crossref_primary_10_1016_j_ophtha_2013_08_014 elsevier_sciencedirect_doi_10_1016_j_ophtha_2013_08_014 elsevier_clinicalkeyesjournals_1_s2_0_S016164201300732X elsevier_clinicalkey_doi_10_1016_j_ophtha_2013_08_014 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | January 2014 2014 2014-01-00 2014-Jan 20140101 |
PublicationDateYYYYMMDD | 2014-01-01 |
PublicationDate_xml | – month: 01 year: 2014 text: January 2014 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Ophthalmology (Rochester, Minn.) |
PublicationTitleAlternate | Ophthalmology |
PublicationYear | 2014 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Obata, Takahashi, Ueta (bib4) 2013; 33 Jampol, Shankle, Schroeder (bib1) 2006; 26 Margolis, Mukkamala, Jampol (bib3) 2011; 129 Wakabayashi, Nishimura, Higashide (bib2) 2010; 88 Kobayashi, Abe, Tamai, Nakazawa (bib6) 2012; 6 Kumano, Nagai, Enaida (bib5) 2013; 90 Jampol (10.1016/j.ophtha.2013.08.014_bib1) 2006; 26 Kobayashi (10.1016/j.ophtha.2013.08.014_bib6) 2012; 6 Wakabayashi (10.1016/j.ophtha.2013.08.014_bib2) 2010; 88 Kumano (10.1016/j.ophtha.2013.08.014_bib5) 2013; 90 Margolis (10.1016/j.ophtha.2013.08.014_bib3) 2011; 129 Obata (10.1016/j.ophtha.2013.08.014_bib4) 2013; 33 |
References_xml | – volume: 129 start-page: 1320 year: 2011 end-page: 1325 ident: bib3 article-title: The expanded spectrum of focal choroidal excavation publication-title: Arch Ophthalmol – volume: 90 start-page: e110 year: 2013 end-page: e118 ident: bib5 article-title: Symptomatic and morphologic difference between choroidal excavations publication-title: Optom Vis Sci – volume: 88 start-page: e87 year: 2010 end-page: e91 ident: bib2 article-title: Unilateral choroidal excavation in the macula detected by spectral-domain optical coherence tomography publication-title: Acta Ophthalmol – volume: 33 start-page: 1201 year: 2013 end-page: 1210 ident: bib4 article-title: Tomographic and angiographic characteristics of eyes with macular focal choroidal excavation publication-title: Retina – volume: 6 start-page: 1373 year: 2012 end-page: 1376 ident: bib6 article-title: Choroidal excavation with polypoidalchoroidal vasculopathy: a case report publication-title: Clin Ophthalmol – volume: 26 start-page: 1072 year: 2006 end-page: 1076 ident: bib1 article-title: Diagnostic and therapeutic challenges publication-title: Retina – volume: 26 start-page: 1072 year: 2006 ident: 10.1016/j.ophtha.2013.08.014_bib1 article-title: Diagnostic and therapeutic challenges publication-title: Retina doi: 10.1097/01.iae.0000248819.86737.a5 – volume: 6 start-page: 1373 year: 2012 ident: 10.1016/j.ophtha.2013.08.014_bib6 article-title: Choroidal excavation with polypoidalchoroidal vasculopathy: a case report publication-title: Clin Ophthalmol doi: 10.2147/OPTH.S33879 – volume: 90 start-page: e110 year: 2013 ident: 10.1016/j.ophtha.2013.08.014_bib5 article-title: Symptomatic and morphologic difference between choroidal excavations publication-title: Optom Vis Sci doi: 10.1097/OPX.0b013e31828736f3 – volume: 129 start-page: 1320 year: 2011 ident: 10.1016/j.ophtha.2013.08.014_bib3 article-title: The expanded spectrum of focal choroidal excavation publication-title: Arch Ophthalmol doi: 10.1001/archophthalmol.2011.148 – volume: 88 start-page: e87 year: 2010 ident: 10.1016/j.ophtha.2013.08.014_bib2 article-title: Unilateral choroidal excavation in the macula detected by spectral-domain optical coherence tomography publication-title: Acta Ophthalmol doi: 10.1111/j.1755-3768.2010.01895.x – volume: 33 start-page: 1201 year: 2013 ident: 10.1016/j.ophtha.2013.08.014_bib4 article-title: Tomographic and angiographic characteristics of eyes with macular focal choroidal excavation publication-title: Retina doi: 10.1097/IAE.0b013e31827b6452 |
SSID | ssj0006634 |
Score | 2.3973925 |
Snippet | To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV).
Retrospective, observational case... Purpose To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV). Design Retrospective,... To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV).PURPOSETo evaluate the clinical... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 246 |
SubjectTerms | Adult Angiogenesis Inhibitors - therapeutic use Choroid - pathology Choroidal Neovascularization - diagnosis Choroidal Neovascularization - drug therapy Choroidal Neovascularization - etiology Coloring Agents Female Fluorescein Angiography Humans Indocyanine Green Intravitreal Injections Male Middle Aged Ophthalmology Retrospective Studies Tomography, Optical Coherence Vascular Endothelial Growth Factor A - antagonists & inhibitors Visual Acuity |
Title | Focal Choroidal Excavation Complicated by Choroidal Neovascularization |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S016164201300732X https://www.clinicalkey.es/playcontent/1-s2.0-S016164201300732X https://dx.doi.org/10.1016/j.ophtha.2013.08.014 https://www.ncbi.nlm.nih.gov/pubmed/24095605 https://www.proquest.com/docview/1490706797 |
Volume | 121 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3batswVGQtjL2M7tqs2_Bgb8PBli-yH0vaUBbawdaysBchyxJxyezS2NDtW_axPbrYdZqGdn0xxpIsWefo3HwuCH1mPA8ykgUu8RLphhL0lJTFoLVyGXEsEmDp2tviJD46C7_Ootlg8K_ntdTU2Yj_vTOu5DFQhWcAVxUl-x-Q7V4KD-Ae4AtXgDBcHwTjiWJEX8bz6rIqcpUg-IozY2LV59zEt2kJ86bPiei8T20IZl8-_XYxr-ds8dtkZtLmBVtRy_jYl-WoZzuYNZpzsUIKQzKOD4yRpnMj_mUbJqy8Kto-nVVnbqLcVR3e202NpoazglULUfTarIHChIS21kqAOig43gq5NRHRK3hliac1Rho-jE1C2jUSb6wN56NKb4hyzgt0ElY78UpG7cPx1HeXeOS5P9Ra1FLU7zsS6BLutzNt-3SJqUfXuj5B2xiUECD72_vT7z-nHacHac3mjjef2YZmav_B9fVtEn02qTZaxDndQc-tbuLsG0R7gQaifImeHlvvi1doovHN6XDJucE3p4dvTvan12cd316js8nh6fjItXU4XB4luHaZ4CCWZzgnkktghxhU1Bx4QR6xmGVCxTMTFbyXY98LRCJ8xoI4kV4usiSFQx-8QVtlVYpd5KTK_zeUnsSEhYRJJoGGRCyTXOR5KPEQBe0WUW6T1KtaKQvaeiOeU7OxVG0sVSVU_XCI3G7UhUnSck__qN192gYgA8ukgGL3jCN3jRNLSxOWdBMK9Uda0daIrA-Y81OLHhQov_qdx0pRNTBXmAK_jklKhuitwZvu60FOV4aP6N2jV7yHnqnDbKyN79FWfdmIDyB_19lHewyuAdJD1k8 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Focal+Choroidal+Excavation+Complicated+by+Choroidal+Neovascularization&rft.jtitle=Ophthalmology+%28Rochester%2C+Minn.%29&rft.au=Xu%2C+Haifeng%2C+MD%2C+PhD&rft.au=Zeng%2C+Fanxing%2C+MD&rft.au=Shi%2C+Depeng%2C+MD&rft.au=Sun%2C+Xiaolei%2C+MD&rft.date=2014&rft.issn=0161-6420&rft.volume=121&rft.issue=1&rft.spage=246&rft.epage=250&rft_id=info:doi/10.1016%2Fj.ophtha.2013.08.014&rft.externalDBID=ECK1-s2.0-S016164201300732X&rft.externalDocID=1_s2_0_S016164201300732X |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01616420%2FS0161642013X00119%2Fcov150h.gif |